Q4 2024 Earnings Conference Call March 27, 2025 4:30 PM ETCompany ParticipantsBruce Mackle - LifeSci Advisors, ...
On track for multiple clinical updates through mid-2026, including further progress from two ongoing clinical programs and initiation of therapeutic dosing of potential new medicine, all based on our ...
More than 900 students from throughout Florida took part in the 70th Annual State Science and Engineering Fair of Florida, ...
Sneak peek at upcoming San Diego community events street fairs, festivals, concerts, performances, art shows, community ...
Larsucosterol Phase 2b AHFIRM trial results published in NEJM Evidence in January 2025 Additional AHFIRM data presented in November 2024 at The Liver Meeting 2024 ...
Proof of principle data from Phase I part of the Phase I/II trial of TG4050 in the adjuvant setting of head and neck cancer. All TG4050-treated patients remained disease-free after median follow-up of ...
Long-term treatment with Duvyzat (givinostat) may help delay the loss of walking ability and lessen the decline in lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results